References
Editors, T. P. B. S. Fifteen years in, what next for PLOS Biology? PLoS Biol. 2018;16:e3000049. https://doi.org/10.1371/journal.pbio.3000049.
Jeang KT. Retrovirology and young Turks. Retrovirology. 2004;1:1. https://doi.org/10.1186/1742-4690-1-1.
Jeang KT. Life after 45 and before 60: the Retrovirology Prize. Retrovirology. 2005;2:26. https://doi.org/10.1186/1742-4690-2-26.
Jeang KT. Small philanthropy and big science: the RETROVIROLOGY prize and Stephen P. Goff. Retrovirology. 2005;2:43. https://doi.org/10.1186/1742-4690-2-43.
Goila-Gaur R, Strebel K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology. 2008;5:51. https://doi.org/10.1186/1742-4690-5-51.
Descours B, et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology. 2012;9:87. https://doi.org/10.1186/1742-4690-9-87.
Sebastian S, Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology. 2005;2:40. https://doi.org/10.1186/1742-4690-2-40.
Weiss RA. The discovery of endogenous retroviruses. Retrovirology. 2006;3:67. https://doi.org/10.1186/1742-4690-3-67.
Towers GJ. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology. 2007;4:40. https://doi.org/10.1186/1742-4690-4-40.
Van Lint C, Bouchat S, Marcello A. HIV-1 transcription and latency: an update. Retrovirology. 2013;10:67. https://doi.org/10.1186/1742-4690-10-67.
Groom HC, et al. Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology. 2010;7:10. https://doi.org/10.1186/1742-4690-7-10.
Hohn O, et al. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology. 2009;6:92. https://doi.org/10.1186/1742-4690-6-92.
Hue S, et al. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology. 2010;7:111. https://doi.org/10.1186/1742-4690-7-111.
Smith RA. Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses. Retrovirology. 2010;7:112. https://doi.org/10.1186/1742-4690-7-112.
Sato E, Furuta RA, Miyazawa T. An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology. 2010;7:110. https://doi.org/10.1186/1742-4690-7-110.
Oakes B, et al. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology. 2010;7:109. https://doi.org/10.1186/1742-4690-7-109.
Robinson MJ, et al. Mouse DNA contamination in human tissue tested for XMRV. Retrovirology. 2010;7:108. https://doi.org/10.1186/1742-4690-7-108.
Smith RA, Gottlieb GS, Miller AD. Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. Retrovirology. 2010;7:70. https://doi.org/10.1186/1742-4690-7-70.
Qiu X, et al. Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology. 2010;7:68. https://doi.org/10.1186/1742-4690-7-68.
Jeziorski E, et al. No evidence for XMRV association in pediatric idiopathic diseases in France. Retrovirology. 2010;7:63. https://doi.org/10.1186/1742-4690-7-63.
Denner J. Detection of a gammaretrovirus, XMRV, in the human population: open questions and implications for xenotransplantation. Retrovirology. 2010;7:16. https://doi.org/10.1186/1742-4690-7-16.
Sakuma T, et al. No evidence of XMRV in prostate cancer cohorts in the Midwestern United States. Retrovirology. 2011;8:23. https://doi.org/10.1186/1742-4690-8-23.
Garson JA, Kellam P, Towers GJ. Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology. 2011;8:13. https://doi.org/10.1186/1742-4690-8-13.
Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R. HIV-1 infection and CD4 T cell depletion in the humanized Rag2−/−gamma c−/− (RAG-hu) mouse model. Retrovirology. 2006;3:76. https://doi.org/10.1186/1742-4690-3-76.
Ahluwalia JK, et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology. 2008;5:117. https://doi.org/10.1186/1742-4690-5-117.
Houzet L, et al. MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology. 2008;5:118. https://doi.org/10.1186/1742-4690-5-118.
Yeung ML, et al. Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology. 2005;2:81. https://doi.org/10.1186/1742-4690-2-81.
Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK. Host-virus interaction: a new role for microRNAs. Retrovirology. 2006;3:68. https://doi.org/10.1186/1742-4690-3-68.
Benkirane M, et al. Professor Mark Wainberg. Retrovirology. 2017;14:30. https://doi.org/10.1186/s12977-017-0353-6.
Freed EO, Ross SR. Retroviruses 2004: review of the 2004 Cold Spring Harbor Retroviruses Conference. Retrovirology. 2004;1:25. https://doi.org/10.1186/1742-4690-1-25.